Literature DB >> 19503634

A single apheresis procedure in the donor may be enough to complete an allograft using the "Mexican method" of non-ablative allografting.

Guillermo J Ruiz-Delgado1, Karla I Gutiérrez-Riveroll, César H Gutiérrez-Aguirre, David Gómez-Almaguer, Renee Eyzaguirre-Zapata, Manuel Priesca-Marin, Martha L González-Carrillo, Guillermo J Ruiz-Argüelles.   

Abstract

BACKGROUND: Since 1999, in Mexico we have been using a regimen to conduct allografts that involves non-myeloablative conditioning and peripheral blood stem cells (PBSC) and have introduced some changes with the main goal of decreasing the cost of the procedure.
MATERIALS AND METHODS: We analysed the salient apheresis features of a group of 175 allogeneic peripheral blood stem cell transplants conducted in two institutions in a 7-year period. The grafts were conducted using the "Mexican" non-myelo ablative conditioning regimen employing oral busulphan, i.v. cyclophosphamide and i.v. fludarabine. In all instances, the apheresis machine employed was the Baxter CS3000 Plus and donors were mobilised with filgrastim. The apheresis procedures were performed on days 0, +1 and +2, the end-point of collection being 5,000 mL of blood/m2 in each procedure. Three apheresis sessions were planned but the number was adjusted according to the cell yield.
RESULTS: The final number of allografted CD34 cells ranged between 0.5 and 25.4 x 10(6)/Kg of the recipient's body weight (median, 5.2 x 10(6)/Kg). One to three apheresis procedures were needed to obtain a product containing more than 0.5 x 10(6) CD34 cells/Kg of the recipient, the median being two procedures; in 72 cases (41%) a single apheresis procedure was sufficient to obtain the target number of CD34 cells. The volumes of apheresis ranged between 50 and 600 mL (median, 400 mL).
CONCLUSIONS: Since the median cost of each apheresis procedure is 900 USD, the fact that two apheresis procedures was spared in 72 cases and one apheresis was spared in another 65 cases, led to a total saving of approximately 188,100 USD. It can be concluded that, in many cases, allogeneic transplants can be completed with a single apheresis session and that there are considerable financial benefits from this practice.

Entities:  

Keywords:  allografts; apheresis; costs saving; transplantation

Mesh:

Substances:

Year:  2009        PMID: 19503634      PMCID: PMC2689067          DOI: 10.2450/2008.0054-08

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  15 in total

1.  A successful and simplified filgrastim primed single apheresis method without large volume apheresis for peripheral blood stem cell collection.

Authors:  F Arpaci; S Kömürcü; B Oztürk; A Ozet; C Kinalp; A Sengül; M Beyzadeoglu; Y Pak; A Yalçin
Journal:  Jpn J Clin Oncol       Date:  2000-03       Impact factor: 3.019

2.  The Mexican approach to conduct allogeneic stem cell transplantation: braking dogmata and facing the Matthew effect.

Authors:  Guillermo J Ruiz-Argüelles
Journal:  Hematology       Date:  2005       Impact factor: 2.269

3.  Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience.

Authors:  G J Ruiz-Argüelles; A Morales-Toquero; B López-Martínez; L-del-C Tarín-Arzaga; C Manzano
Journal:  Bone Marrow Transplant       Date:  2005-10       Impact factor: 5.483

4.  Large-volume leukapheresis for peripheral blood stem cell collection in children: a simplified single-apheresis approach.

Authors:  A Alegre; M A Díaz; L Madero; A Granda; A de la Vega; M Villa; M J Fernández-Villalta; J J Gil-Fernández; J M Fernández-Rañada
Journal:  Bone Marrow Transplant       Date:  1996-06       Impact factor: 5.483

5.  Harvesting peripheral blood progenitor cells from healthy donors with a short course of recombinant human granulocyte-colony-stimulating factor.

Authors:  M Martino; F Morabito; I Callea; A Pontari; G Irrera; G Pucci; A Dattola; G Messina; G Console; P Iacopino
Journal:  Transfus Med       Date:  2005-08       Impact factor: 2.019

6.  Allogeneic hematopoietic stem cell transplantation with non-myeloablative conditioning in patients with acute myelogenous leukemia eligible for conventional allografting: a prospective study.

Authors:  Guillermo J Ruiz-Argüelles; David Gómez-Almaguer; Jose David-Gomez-Rangel; Jorge Vela-Ojeda; Olga G Cantú-Rodríguez; José C Jaime-Pérez; Oscar González-Llano; José L Herrera-Garza
Journal:  Leuk Lymphoma       Date:  2004-06

7.  Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis.

Authors:  R Pettengell; G R Morgenstern; P J Woll; J Chang; M Rowlands; R Young; J A Radford; J H Scarffe; N G Testa; D Crowther
Journal:  Blood       Date:  1993-12-15       Impact factor: 22.113

Review 8.  Breaking dogmata to help patients: non-myeloablative haematopoietic stem cell transplantation.

Authors:  Guillermo J Ruiz-Argüelles; David Gómez-Almaguer
Journal:  Expert Opin Biol Ther       Date:  2004-10       Impact factor: 4.388

9.  Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?

Authors:  G J Ruiz-Argüelles; L C Tarin-Arzaga; M L Gonzalez-Carrillo; K I Gutierrez-Riveroll; R Rangel-Malo; C H Gutiérrez-Aguirre; O G Cantú-Rodríguez; D Gómez-Almaguer; S Giralt
Journal:  Bone Marrow Transplant       Date:  2008-07       Impact factor: 5.483

10.  Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma.

Authors:  H M Jones; S A Jones; M J Watts; A Khwaja; W Mills; A Fielding; A H Goldstone; D C Linch
Journal:  J Clin Oncol       Date:  1994-08       Impact factor: 44.544

View more
  2 in total

1.  Cost structure and clinical outcome of a stem cell transplantation program in a developing country: the experience in northeast Mexico.

Authors:  José Carlos Jaime-Pérez; Alberto Carlos Heredia-Salazar; Olga G Cantú-Rodríguez; Homero Gutiérrez-Aguirre; César Daniel Villarreal-Villarreal; Consuelo Mancías-Guerra; José Luís Herrera-Garza; David Gómez-Almaguer
Journal:  Oncologist       Date:  2015-03-06

2.  Bone Marrow Transplantation in Patients With Acute Leukemia In Cuba: Results From the Last 30 Years and New Opportunities Through International Collaboration.

Authors:  José Carnot Uria; Calixto Hernández Cruz; Jorge Muñío Perurena; Wilfredo Torres Yribar; Jesús Diego de la Campa; Concepción Del Castillo Carrillo; Yusaima Rodríguez Fraga; Julio A López Silva; Kali Cepero Llauger; Ibis K Pardo Ramírez; Aliette García García; Karen Sweiss; Pritesh R Patel; Damiano Rondelli
Journal:  J Glob Oncol       Date:  2018-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.